Omnicell to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Omnicell (OMCL), a company focused on pharmacy care delivery transformation, has announced its upcoming presentation at the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Wednesday, January 15, 2025, at 1:30 p.m. PT.
Interested parties can access both live and archived versions of the presentation through the company's investor relations website at their events and presentations page. This participation in one of healthcare industry's premier conferences demonstrates Omnicell's continued engagement with the investment community.
Omnicell (OMCL), un'azienda focalizzata sulla trasformazione della consegna dell'assistenza farmaceutica, ha annunciato la sua prossima presentazione alla 43ª Conferenza annuale J.P. Morgan Healthcare. La presentazione è programmata per mercoledì 15 gennaio 2025, alle 13:30 PT.
Le parti interessate possono accedere sia alle versioni live che a quelle registrate della presentazione tramite il sito web per gli investitori dell'azienda, nella sezione eventi e presentazioni. Questa partecipazione a una delle conferenze più importanti del settore sanitario dimostra il continuo impegno di Omnicell con la comunità degli investitori.
Omnicell (OMCL), una empresa centrada en la transformación de la entrega de atención farmacéutica, ha anunciado su próxima presentación en la 43ª Conferencia Anual de J.P. Morgan Healthcare. La presentación está programada para el miércoles 15 de enero de 2025, a la 1:30 p.m. PT.
Las partes interesadas pueden acceder a versiones en vivo y archivadas de la presentación a través del sitio web de relaciones con inversores de la empresa en su página de eventos y presentaciones. Esta participación en una de las conferencias más importantes de la industria de la salud demuestra el continuo compromiso de Omnicell con la comunidad inversora.
Omnicell (OMCL)은 약국 관리 서비스 혁신에 중점을 둔 회사로, 제43회 JP모건 의료 회의에서의 발표를 발표했습니다. 발표는 2025년 1월 15일 수요일 오후 1:30 PT로 예정되어 있습니다.
관심 있는 분들은 회사의 투자자 관계 웹사이트에서 이벤트 및 발표 페이지를 통해 발표의 라이브 및 아카이브 버전을 모두 이용할 수 있습니다. 의료 산업의 주요 회의 중 하나에 참여함으로써 Omnicell은 투자자 커뮤니티와의 지속적인 관계를 보여줍니다.
Omnicell (OMCL), une entreprise axée sur la transformation de la livraison des soins pharmaceutiques, a annoncé sa prochaine présentation lors de la 43e Conférence annuelle J.P. Morgan Healthcare. La présentation est prévue pour mercredi 15 janvier 2025, à 13h30 PT.
Les parties intéressées peuvent accéder aux versions en direct et archivées de la présentation via le site Web des relations avec les investisseurs de l'entreprise, sur sa page d'événements et de présentations. Cette participation à l'une des principales conférences de l'industrie des soins de santé démontre l'engagement continu d'Omnicell envers la communauté des investisseurs.
Omnicell (OMCL), ein Unternehmen, das sich auf die Transformation der Pharmazieversorgung konzentriert, hat seine bevorstehende Präsentation auf der 43. jährlichen J.P. Morgan Healthcare-Konferenz angekündigt. Die Präsentation ist für Mittwoch, den 15. Januar 2025, um 13:30 Uhr PT geplant.
Interessierte Parteien können sowohl auf die Live- als auch auf die archivierten Versionen der Präsentation über die Investor Relations-Website des Unternehmens auf deren Seite für Veranstaltungen und Präsentationen zugreifen. Diese Teilnahme an einer der renommiertesten Konferenzen der Gesundheitsbranche zeigt Omnicells fortwährendes Engagement gegenüber der Investment-Community.
- None.
- None.
Live and archived webcasts of the presentation will be available through the Omnicell website at: https://ir.omnicell.com/events-and-presentations/
About Omnicell
Since 1992, Omnicell has been committed to transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care. Through a comprehensive portfolio of robotics, smart devices, software, and expert services, Omnicell solutions are helping healthcare facilities worldwide to uncover cost savings, improve labor efficiency, establish new revenue streams, enhance supply chain control, support compliance, and move closer to the industry-defined vision of the Autonomous Pharmacy. To learn more, visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
OMCL-E
View source version on businesswire.com: https://www.businesswire.com/news/home/20250108886133/en/
Kathleen Nemeth
Senior Vice President, Investor Relations
ir@omnicell.com
Source: Omnicell, Inc.
FAQ
When is Omnicell (OMCL) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch Omnicell's (OMCL) J.P. Morgan Healthcare Conference presentation?
Which annual J.P. Morgan Healthcare Conference will Omnicell (OMCL) be participating in?
Will Omnicell's (OMCL) J.P. Morgan Healthcare Conference presentation be available after the event?
